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Abstract Brain arteriovenous malformations (BAVMs) are
an important cause of intracranial hemorrhage (ICH) in
young adults. A small percent of BAVMs is due to
hereditary hemorrhagic telangiectasia 1 and 2 (HHT1 and
2), which are caused by mutations in two genes involved in
transforming growth factor-β signaling: endoglin (Eng),
and activin-like kinase 1 (Alk1). The BAVM phenotype
has incomplete penetrance in HHT patients, and the
mechanism is unknown. We tested the hypothesis that a
“response-to-injury” triggers abnormal vascular (dysplasia)
development, using Eng and Alk1 haploinsufficient mice.
Adeno-associated virus (AAV) expressing vascular endo-
thelial growth factor (VEGF) was used to mimic the injury
conditions. VEGF overexpression caused a similar degree
of angiogenesis in the brain of all groups, except that the
cortex of Alk1
+/− mice had a 33% higher capillary density
than other groups. There were different levels of cerebro-
vascular dysplasia observed in haploinsufficient mice
(Eng
+/−>Alk1
+/−), which simulates the relative penetrance
of BAVM in HHT patients (HHT1>HHT2). Few dysplastic
capillaries were observed in AAV-LacZ-injected mice. Our
data indicate that both angiogenic stimulation and genetic
alteration are necessary for the development of vascular
dysplasia, suggesting that anti-angiogenic therapies might
be adapted to slow the progression of the disease and
decrease the risk of spontaneous ICH.
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Introduction
Brain arteriovenous malformations (BAVM) are an impor-
tant cause of intracranial hemorrhage (ICH) in young
adults. Roughly 2–5% of all brain AVMs is due to
hereditary hemorrhagic telangiectasia (HHT), in which the
main subtypes (HHT1 and 2) are caused by loss-of-function
mutations in two genes involved in transforming growth
factor-β signaling: endoglin (Eng) and activin-like kinase 1
(Alk1). HHT is an autosomal dominant disorder, but the
BAVM lesion has incomplete penetrance, and the mecha-
nism is unknown [1]. The BAVM lesional phenotype
includes an active angiogenic and inflammatory component
that is inconsistent with a static congenital anomaly [2],
suggesting that a “response-to-injury” may explain incom-
plete penetrance of BAVM in HHT patients. There is
important new evidence from extracranial tissues that such
response-to-injury takes place in AVM development [3].
To explore this general hypothesis, we overexpressed
vascular endothelial growth factor (VEGF), an angiogenic
factor upregulated in injured tissue and BAVM lesional
tissue, in the brain of Eng
+/− and Alk1
+/− mice. We showed
that vascular dysplasia occurs only after VEGF stimulation
and is more pronounced in Eng
+/− than in Alk1
+/− mice.
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Animals
Experimental procedures for using laboratory animals were
approved by the Institutional Animal Care and Use
Committee of the University of California, San Francisco
(UCSF). Eng
+/− and Alk1
+/− mice were obtained from Dr.
Douglas Marchuk's laboratory at Duke University and bred
at UCSF's animal facility. These mice have been back-
crossed with C57BL mice for more than ten generations in
our laboratory. Thus, they are in C57BL/6 background.
C57BL wild type (WT) mice were used as control. Adult
male Eng
+/−, Alk1
+/−, Eng/Alk1
+/− (Eng and Alk1 double
heterozygous knockout), and WT mice weighing 25–30 g
(8 to 10 weeks old) were used for the experiments.
AAV Gene Transfer
Mice were anesthetized using ketamine/xylazine (100/
10 mg/kg body weight) intraperitoneally and placed in a
stereotactic frame with a mouth holder (David Kopf
Instruments, Tujunga, CA, USA). A burr hole was drilled
in the pericranium 2 mm lateral to the sagittal suture and
1 mm posterior to the coronal suture. A 10 µl Hamilton
syringe was inserted into the right basal ganglia. For
cortical injection, the needle was inserted 1 mm into the
cortex and advanced 2 mm parallel to the surface. Two
microliters of viral suspension containing 2×10
9 genome
copies of adeno-associated virus (AAV)-VEGF or AAV-
LacZ, AAV vectors with cytomegalovirus (CMV) pro-
moter driving VEGF or LacZ gene expression, was slowly
injected at a rate of 0.2 µl per minute.
Fig. 1 In the striatum. A Injection site (gray square). B Angiogenic
foci and dysplastic capillaries (arrows). Inserts are enlarged images of
dysplastic capillaries. Scale bars are 100 (top panel) and 50 µm
(bottom panel). C, D The capillary density and dysplasia index.
Asterisk, p<0.05 vs. AAV-LacZ group. Number sign, p<0.05 vs.
AAV-VEGF-transduced WT or Alk1
+/− mice. VEGF: AAV-VEGF-
injected mice, LacZ: AAV-LacZ-injected mice. N=6
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Brain specimens were collected 6 weeks after the vector
injection. The brain was removed, snap-frozen with dry ice,
and stored at −80°C. A series of 20 µm cryostat coronal
sections were collected. Sections were fixed with 4%
paraformaldehyde for 30 min and incubated overnight with
fluorescein-lycopersicin esculentum lectin (Vector Labora-
tories, Burlingame, CA, USA), 2 µg/ml at 4°C.
Two coronal sections, located 0.5 mm rostral to and
0.5 mm caudal to the injection site, were chosen for vessel
quantification.Picturesweretakenfromthreeareas(left,right,
and bottom of the injection site) of each section using ×10
microscope objective lens. Capillary density (CD, the number
of capillaries per ×10 objective field) and the dysplasia index
(the number of capillaries with lumen >15 µm per 200
capillaries) were quantified using Image J [4]. Two inves-
tigators without knowledge of treatment conditions per-
formed the quantification separately.
Data are mean±SD. Differences among groups were
analyzed by one-way analysis of variance followed by
Fisher's protected least significant difference test.
Results
In the striatum, the AAV-VEGF-injected mice had higher CD
than the AAV-LacZ-injected mice (P<0.05): Eng
+/− (237±30
vs. 174±24), Alk1
+/− (246±37 vs.173±32), or WT (249±33
vs.179±28). There were no differences among the groups
(P>0.05). The dysplasia index was higher in the striatum of
AAV-VEGF-injected Eng
+/− mice (3.0±1.0) than in Alk1
+/−
mice (0.7±0.5; P<0.05). Few dysplastic capillaries were
detected in the striatum of AAV-LacZ-injected Eng
+/− and
Alk1
+/− mice and AAV-VEGF-injected WT mice (Fig. 1).
Fig. 2 In the cortex. A Injection site (gray square). B Angiogenic foci
and dysplastic capillaries (arrows). Inserts are enlarged images of
dysplastic capillaries. Scale bars are 100 (top panel) and 50 µm
(bottom panel). C, D The capillary density and dysplasia index.
Asterisk (in C), p<0.05 vs. AAV-LacZ group. Asterisk (in D), p<0.05
vs. AAV-VEGF-transduced WT. Number sign, p<0.05 vs. AAV-
VEGF-transduced Alk1
+/− mice. VEGF: AAV-VEGF-injected mice,
LacZ: AAV-LacZ-injected mice. N=3
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Alk1
+/− mice (342±76) had a 33% higher CD than Eng/
Alk1
+/− (258±56) and Eng
+/− (259±46) mice (P<0.05).
Vascular dysplasia was also similar to that seen in the
striatum, but differences among groups were less marked.
The dysplasia index was higher in Eng
+/− mice (2.3±1.2)
than in Alk1
+/− (1.2±0.8) (P<0.05; Fig. 2).
The Eng/Alk1
+/− mice displayed a dysplasia index similar to
the Alk1
+/− group (1.5±1.1). The dysplasia index trended
higher in the cortex of 6-month-old (3.7±1.4) than in 3-month-
old Eng
+/− mice after AAV-VEGF injection (P=0.16).
Discussion
We demonstrated that (1) VEGF stimulated similar CD
increases in the striatum or cortex of Eng
+/−, Alk1
+/−, and
WT mice (except in Alk1
+/− mice, which had a higher
cortical CD than the other groups); (2) VEGF induced
different levels of cerebrovascular dysplasia in Eng
+/− and
Alk1
+/− mice (Eng
+/−>Eng/Alk1
+/−>Alk1
+/−); and (3)
minimal cerebrovascular dysplasia was observed in hap-
loinsufficient mice without VEGF stimulation.
There is no good model of BAVM that mimics the
human disease [5]. We have developed an intermediate
phenotype—cerebrovascular dysplasia—that is not a direct
disease model but may be useful in studying vascular
responses in Eng
+/− and Alk1
+/− mice separately [4, 6].
Here, we provided the first direct comparison of the CD and
dysplastic index in the VEGF-stimulated brain of Eng
+/−
and Alk1
+/− mice, and showed that the degree of dysplasia
in Eng
+/− and Alk1
+/− mice simulated the prevalence of
BAVM in HHT patients. Although we used VEGF, it is
likely that other factors upregulated during tissue injury,
such as cytokines involved in inflammatory reaction, might
also play primary, synergistic, and/or permissive roles.
Satomi et al. found that three out of ten Eng
+/− mice
spontaneously develop various types of vascular dysplasia
[7]. The abnormal morphology we observed is similar to
theirs, but the number of dysplastic vessels is greater after
VEGF stimulation. It is possible that our AAV-LacZ-injected
Eng
+/− mice had a similar degree of dysplasia as those in the
Satomi study, but our methods were not sensitive enough to
detect it. Further, Satomi et al. used 6- to 10-month-old mice.
We found a trend toward increased dysplasia in the brain of
6-month-old Eng
+/− mice than in 3-month-old mice, suggest-
ing that aging plays a role in cerebrovascular dysplasia
development in Eng-deficient mice.
We do not have an explanation for the anomalous
observation that cortical injection of VEGF in Alk1 mice
gave a more robust CD response, nor do we understand
why double-knockout mice appeared to lie midway
between Alk1
+/− and Eng
+/− mice, in terms of dysplasia.
Although other groups found a reduced angiogenic
response in adult Eng
+/− mice in ischemic hind limb and
tumor models [8, 9], we induced a similar degree of
angiogenesis in the brain of mice with different genetic
backgrounds, except that Alk1
+/− mice had slightly higher
CD in the cortex than other groups. Gene expression assays
in the local microenvironment of VEGF-stimulated brain
would help clarify these observations.
Summary
We have provided evidence that the development of vascular
dysplasia in Eng
+/− or Alk1
+/− mice is greatly magnified by
VEGF overexpression, the degree of which simulates the
relative prevalence of BAVM in HHT 1 and 2. If dysplasia
can be taken as an intermediate phenotype for BAVM, then
our data support a “response-to-injury” hypothesis. Although
t h ec l i n i c a ln a t u r eo fs u c ha ni n j u r yo ra c q u i r e dc h a n g ei n
vascular microenvironment is unknown, identification of
pathways and modifiers may lead to the discovery of ways to
manipulate signaling to decrease the prevalence of BAVM
formation in HHT patients and reduce the incidence of ICH.
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